Document Detail

Canalith Repositioning Procedures among 965 Patients with Benign Paroxysmal Positional Vertigo.
MedLine Citation:
PMID:  23147839     Owner:  NLM     Status:  Publisher    
Background: Canalith repositioning procedure (CRP) has increasingly been utilized for the last 15 years for the treatment of benign paroxysmal positional vertigo (BPPV). We assess the short- and long-term efficacy of CRP on the treatment of patients with BPPV. Methods: Nine hundred sixty-five patients (481 men and 484 women, from 18 to 87 years of age) were enrolled in this prospective study during 1995-2010. Inclusion criteria were a patient history compatible with BPPV and a positive provocative maneuver (either Dix-Hallpike or Roll test). Reported duration of symptoms at the time of their first examination varied from 1 day to 18 months. Variants of the Epley and Barbeque maneuver were used for posterior and anterior canal involvement, and horizontal canal involvement, respectively. Short-term follow-up was obtained 48 h and 7 days after initial treatment, whereas long-term follow-up was obtained at repeated 6-month intervals. Results: Symptoms subsided immediately in 819 patients (85%) by the first CRP. Only 19 patients (2%) required CRP more than 3 times. Patients' mean follow-up was 74 months; symptom recurrence was noted in 139 patients. A statistically significantly higher recurrence rate was noted in elderly people or those with head trauma or a history of vestibular neuropathy (p < 0.001). Conclusions: This study provides class IV evidence that CRP remains an efficient and long-lasting noninvasive treatment for BPPV, especially for younger patients without a history of head trauma or vestibular neuropathy. Elderly people have a significantly higher recurrence rate requiring additional education to minimize potential morbidity of their falls.
E Prokopakis; I M Vlastos; M Tsagournisakis; P Christodoulou; H Kawauchi; G Velegrakis
Related Documents :
12172269 - Risk-benefit analysis of using the middle fossa approach for acoustic neuromas with >10...
11904019 - Microvascular decompression in the management of glossopharyngeal neuralgia: analysis o...
12589849 - The effect of recombinant interferon alpha treatment on hearing thresholds in patients ...
24420839 - Is single dose povidone iodine sclerotherapy effective in chyluria?
23968339 - Clinical efficacy and compliance of sublingual immunotherapy with dermatophagoides fari...
23297319 - High-dose-rate interstitial brachytherapy for gynecologic malignancies--dosimetric chan...
3587859 - Filtration surgery in black patients: early results in a west indian population.
11579369 - Effect of early treatment with captopril and metoprolol singly and together on postinfa...
22771679 - Long-term benefit of implantable cardioverter/defibrillator therapy after elective devi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-06
Journal Detail:
Title:  Audiology & neuro-otology     Volume:  18     ISSN:  1421-9700     ISO Abbreviation:  Audiol. Neurootol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9606930     Medline TA:  Audiol Neurootol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  83-88     Citation Subset:  -    
Copyright Information:
Copyright © 2012 S. Karger AG, Basel.
Department of Otorhinolaryngology, University of Crete School of Medicine, Heraklion, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A chemically-defined screening platform reveals behavioral similarities between primary human mesenc...
Next Document:  Neural interfaces for the brain and spinal cord-restoring motor function.